Search Results

Insmed’s freshly approved lung condition drug soared past sales expectations for 2025, netting $144.6 million in its first full quarter of sales.

Tonix Pharmaceuticals Holding Corp. announced that the Company has signed securities purchase agreements with certain healthcare-focused institutional investors that have agreed to provide up to $144 million in gross proceeds to Tonix through a registered direct offering that includes initial upfront funding of $30 million.

Recce Pharmaceuticals Ltd, the Company developing a new class of synthetic anti-infectives, is pleased to announce it received additional non-dilutive funds from Radium Capital for A$973,144 for Recce’s future research and development tax incentive.

The National Disease Research Interchange, in collaboration with the University of Maryland School of Medicine and Johns Hopkins All Children’s Hospital, has been awarded a research grant of $14.4M by the National Institutes of Health with a goal to transform our knowledge of how much genetic variation there is in cells and tissues throughout our bodies.

LifeScan announced that the peer-reviewed Journal of Diabetes Science and Technology has published Improved Glycemic Control Using a Bluetooth Connected Blood Glucose Meter and a Mobile Diabetes App: Real-World Evidence From Over 144,000 People With Diabetes, detailing results from a retrospective analysis of real-world data from over 144,000 people with diabetes – one of the largest combined blood glucose meter and mobile diabetes app datasets ever published.

The telehealth market size is expected to hit USD 144.9 billion by 2028 from USD 41 billion in 2021 and growing at a CAGR of 18.8% over the forecast period 2021 to 2030.